Aeterna Zentaris : Audited Consolidated Financial Statements

Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K

Aeterna Zentaris : Audited Consolidated Financial Statements of Ceapro Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 - Form 6-K

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Montreal , Quebec , Canada , United States , Germany , Canadian , Stacy Prefontaine , Ulrich Kosciessa , Gilles Gagnon , Raymond Chabot Grant Thornton , Aeterna Zentaris Inc , Ceapro Inc , Management Of The Company , University Of Alberta , Nrdc Inc , Office Equipment , Angiogenesis Foundation , Audit Committee , Shareholders Of Ceapro Inc , International Financial Reporting Standards , Public Company Accounting Oversight Board United States , Foreign Exchange Risk , Financial Statements Of Ceapro Inc , Public Accounting Firm , Ceaprop Ei Inc , Nasdaq , Exchange Commission , Venture Exchange , International Accounting Standards Board , Audited Consolidated Financial Statements , Independent Registered Public Accounting , Consolidated Financial , International Accounting Standards , Chief Executive Officer , Public Company Accounting Oversight Board , Ended December , Cash Flows , Canada Business Corporations Act , Best Market , Common Shares , Canadian Chartered Banks , Exchange Risk , National Research Council , Industrial Research Assistance Program , Aeterna Zentaris ,